Fludarabine phosphate: a new active agent in hematologic malignancies

Semin Hematol. 1994 Jan;31(1):28-39.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Hematologic Diseases / drug therapy*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Lymphoma / drug therapy
  • Vidarabine Phosphate / analogs & derivatives*
  • Vidarabine Phosphate / chemistry
  • Vidarabine Phosphate / pharmacokinetics
  • Vidarabine Phosphate / therapeutic use
  • Waldenstrom Macroglobulinemia / drug therapy

Substances

  • Vidarabine Phosphate
  • fludarabine phosphate